{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:52:09Z","timestamp":1759539129785,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.fct.2023.113898","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T21:28:22Z","timestamp":1686950902000},"page":"113898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Response to Barriere et al."],"prefix":"10.1016","volume":"178","author":[{"given":"Stephanie","family":"Seneff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Nigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2023.113898_bib1","series-title":"Chapter 3 in Regulation of Cancer Immune Checkpoints. Molecular and Cellular Mechanisms and Therapy","article-title":"Roles of PD-1\/PD-L1 pathway: signaling, cancer, and beyond","author":"Ai","year":"2018"},{"issue":"3","key":"10.1016\/j.fct.2023.113898_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajic.2021.12.019","article-title":"How many lives do COVID vaccines save? Evidence from Israel","volume":"50","author":"Arbel","year":"2022","journal-title":"Am. J. Infect. Control"},{"issue":"10","key":"10.1016\/j.fct.2023.113898_bib3","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.fct.2023.113898_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18505","article-title":"Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMA Netw. Open."},{"issue":"8","key":"10.1016\/j.fct.2023.113898_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1631\/jzus.B2000808","article-title":"Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses","volume":"22","author":"Chen","year":"2021","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"79","key":"10.1016\/j.fct.2023.113898_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.fct.2023.113898_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.fct.2023.113898_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.fct.2023.113898_bib8","doi-asserted-by":"crossref","unstructured":"Koneczny I. Update on IgG4-mediated autoimmune diseases: new insights and new family members. Autoimmun. Rev. 020; 19(10): 102646. doi: 10.1016\/j.autrev.2020.102646.","DOI":"10.1016\/j.autrev.2020.102646"},{"issue":"1","key":"10.1016\/j.fct.2023.113898_bib9","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1515\/cclm-2022-0787","article-title":"Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV-2 mRNA or vector vaccine","volume":"61","author":"Loacker","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.fct.2023.113898_bib10","first-page":"196","article-title":"Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents","volume":"7","author":"Mansanguan","year":"2022","journal-title":"Trav. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.fct.2023.113898_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.kint.2021.06.002","article-title":"Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine","volume":"100","author":"Masset","year":"2021","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.fct.2023.113898_bib12","doi-asserted-by":"crossref","first-page":"ytab054","DOI":"10.1093\/ehjcr\/ytab054","article-title":"Sudden cardiac death risk in contact sports increased by myocarditis: a case series","volume":"5","author":"Massoulli\u00e9","year":"2021","journal-title":"European Heart Journal - Case Reports"},{"key":"10.1016\/j.fct.2023.113898_bib13","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2023.113898_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656700","article-title":"SARS-CoV-2 spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia","volume":"12","author":"Mishra","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2023.113898_bib15","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/vaccines10101651","article-title":"A case report: multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19","volume":"10","author":"M\u00f6rz","year":"2022","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.fct.2023.113898_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.fct.2023.113898_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11914-019-00537-7","article-title":"Exosomes and extracellular RNA in muscle and bone aging and crosstalk","volume":"17","author":"Qin","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"issue":"3","key":"10.1016\/j.fct.2023.113898_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annonc.2021.12.006","article-title":"COVID-19 vaccination and breakthrough infections in patients with cancer","volume":"33","author":"Schmidt","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.fct.2023.113898_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00392-020-01800-z","article-title":"Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge","volume":"110","author":"Sechi","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.fct.2023.113898_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41419-022-05548-4","article-title":"Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy","volume":"14","author":"Spiliopoulou","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fct.2023.113898_bib21","first-page":"542","volume":"vol. 28","author":"Trougakos","year":"2022"},{"key":"10.1016\/j.fct.2023.113898_bib22","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/jcm11082219","article-title":"The incidence of myocarditis and pericarditis in post COVID-19 unvaccinated patients a large population-based study","volume":"11","author":"Tuvali","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fct.2023.113898_bib23","article-title":"IgG4 antibodies induced by mRNA vaccines generate immune tolerance to SARS-CoV-2 spike protein by suppressing the immune system","volume":"27","author":"Uversky","year":"2023","journal-title":"Preprints Mar"},{"key":"10.1016\/j.fct.2023.113898_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.fct.2023.113898_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS- CoV-2 BQ and XBB subvariants","volume":"86","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.fct.2023.113898_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-021-02652-2","article-title":"The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis","volume":"24","author":"Yu","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.fct.2023.113898_bib27","first-page":"679","article-title":"Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:26:59Z","timestamp":1759530419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691523003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":28,"alternative-id":["S0278691523003009"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2023.113898","relation":{},"ISSN":["0278-6915"],"issn-type":[{"type":"print","value":"0278-6915"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Barriere et al.","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.113898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.113897","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113898"}}